Home » Topics » BioWorld Science

BioWorld Science
RSS

D-21266 demonstrates advantages over miltefosine in vivo

May 12, 1997

Glaxo obtains license to technology and porphyrin compound for dermatological diseases

May 12, 1997

Fujisawa's Prograf cleared by FDA for use in kidney transplantation

May 9, 1997

Anti-HBV/anti-HIV L-nucleoside analogue described

May 9, 1997

New class of topo I inhibitors designed for oral administration

May 9, 1997

Natural cancer immunotherapeutic discovered by Yonsei University researchers

May 9, 1997

Novel EGF receptor TK inhibitor described by Mitsubishi

May 9, 1997

BM-92.0700: a promising anticancer clinical candidate

May 9, 1997

ONYX-015 demonstrates in vitro and in vivo efficacy

May 9, 1997

Preclinical data for ZD-1839, an EGF tyrosine kinase inhibitor

May 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...